These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22129316)

  • 41. Sildenafil citrate.
    Dimens Crit Care Nurs; 2000; 19(3):13. PubMed ID: 11998000
    [No Abstract]   [Full Text] [Related]  

  • 42. 10-Year analysis of adverse event reports to the Food and Drug Administration for phosphodiesterase type-5 inhibitors.
    Lowe G; Costabile RA
    J Sex Med; 2012 Jan; 9(1):265-70. PubMed ID: 22023666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood pressure control and sildenafil--carrot stick or sword of Damocles?
    Yao SS; Messerli FH
    Am J Cardiol; 2007 Aug; 100(3):552-3. PubMed ID: 17659945
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms.
    Miller MS
    Ann Pharmacother; 2013 Feb; 47(2):278-83. PubMed ID: 23386068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
    Hatzimouratidis K; Hatzichristou DG
    Drugs; 2005; 65(12):1621-50. PubMed ID: 16060698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review assessing the economic impact of sildenafil citrate (Viagra) in the treatment of erectile dysfunction.
    Martin AL; Huelin R; Wilson D; Foster TS; Mould JF
    J Sex Med; 2013 May; 10(5):1389-400. PubMed ID: 23347555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex and the patient with cardiovascular risk factors: focus on sildenafil.
    Kloner RA
    Am J Med; 2000 Dec; 109 Suppl 9A():13S-21S; discussion 29S-30S. PubMed ID: 11137498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of sildenafil citrate on the cardiovascular system.
    Shinlapawittayatorn K; Chattipakorn S; Chattipakorn N
    Braz J Med Biol Res; 2005 Sep; 38(9):1303-11. PubMed ID: 16138212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.
    Corbin JD; Francis SH; Webb DJ
    Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypotensive potential of sildenafil and tamsulosin during orthostasis.
    Nieminen T; Kööbi T; Tammela TL; Kähönen M
    Clin Drug Investig; 2006; 26(11):667-71. PubMed ID: 17163302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study.
    Turk S; Solak Y; Kan S; Atalay H; Kilinc M; Agca E; Bodur S
    Nephrol Dial Transplant; 2010 Nov; 25(11):3729-33. PubMed ID: 20466680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
    Traish A; Kim N
    J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical update on sildenafil citrate.
    Osterloh IH; Riley A
    Br J Clin Pharmacol; 2002 Mar; 53(3):219-23. PubMed ID: 11874383
    [No Abstract]   [Full Text] [Related]  

  • 57. Sildenafil in idiopathic pulmonary fibrosis.
    Mubarak K
    N Engl J Med; 2010 Nov; 363(22):2170; author reply 2170-1. PubMed ID: 21105802
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiovascular effects of sildenafil citrate and recommendations for its use.
    Kloner RA; Zusman RM
    Am J Cardiol; 1999 Sep; 84(5B):11N-17N. PubMed ID: 10503571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia.
    Bhatt-Mehta V; Donn SM
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):393-5. PubMed ID: 24866752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.